FrancophonIA/ELRC3.0 huggingface dataset:
English: Uncommon side effects (may affect up to 1 in 100 people) include hypersensitivity (e.g. swelling in the mouth and throat, itching, rash); diabetes or the worsening of diabetes, occasionally associated with ketoacidosis (ketones in the blood and urine) or coma; seizures, usually associated with a history of seizures (epilepsy); muscle stiffness or spasms (including eye movements); restless legs syndrome; problems with speech; stuttering; slow heart rate; sensitivity to sunlight; bleeding from the nose; abdominal distension; memory loss or forgetfulness; urinary incontinence; lack of ability to urinate; hair loss; absence or decrease in menstrual periods; and changes in breasts in males and females such as an abnormal production of breast milk or abnormal growth.
Norwegian Bokmål: Mindre vanlige bivirkninger (kan ramme opptil 1 av 100 personer) omfatter overfølsomhet (f.eks hevelse i munn og hals, kløe og utslett), diabetes eller forverring av diabetes, av og til forbundet med ketoacidose (ketoner i blod og urin) eller koma, kramper, vanligvis i tilfeller med tidligere krampeanfall (epilepsi), muskelstivhet eller rykninger (inkludert øyebevegelser), rastløse bein, problemer med å snakke, stamming, langsom hjerterytme, følsomhet for sollys, neseblødning, oppblåst mage, hukommelsestap eller glemsomhet, urinlekkasje, manglende evne til å urinere, hårtap, fravær eller mindre menstruasjonsperioder og endringer i brystene hos menn eller kvinner slik som unormal produksjon av brystmelk eller unormal vekst.
English: LIST OF EXCIPIENTS Contains, among others, Lactose monohydrate.
Norwegian Bokmål: Inneholder blant annet laktosemonohydrat.
English: In clinical trials, clinically meaningful QTc prolongations (Fridericia QT correction [QTcF] ≥500 milliseconds [msec] at any time post baseline in patients with baseline QTcF <500 msec) were uncommon (0.1% to 1%) in patients treated with olanzapine, with no significant differences in associated cardiac events compared to placebo.
Norwegian Bokmål: I kliniske studier hos pasienter behandlet med olanzapin, var QTc-forlengelse av klinisk betydning (Fridericia QT-korreksjon [QTcF] ≥500 millisekunder [msek] på noe tidspunkt etter baseline hos pasienter med baseline QTcF <500 millisek) mindre vanlig (0,1 %-1 %).
English: If you notice any of these symptoms seek medical advice immediately; - a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness (the frequency of this side effect cannot be estimated from the available data).
Norwegian Bokmål: • en kombinasjon av feber, hurtig pust, svetting, muskelstivhet og døsighet eller søvnighet (frekvensen av denne bivirkningen kan ikke anslås utifra tilgjengelige data).
English: Elevated triglyceride levels2,5
Norwegian Bokmål: Forhøyede triglyseridnivåer
English: Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements (dyskinesias); constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males
Norwegian Bokmål: Vanlige bivirkninger (kan forekomme hos inntil 1 av 10 personer) omfatter nivåendringer av enkelte blodceller, sirkulerende fettstoffer og tidlig i behandlingen midlertidig økning i leverenzymer, forhøyet blodsukker og urinsukker, økning i nivåer av urinsyre og kreatinkinase i blodet, øket sultfølelse, svimmelhet, rastløshet, skjelving, uvanlige bevegelser (dyskinesier), forstoppelse, tørrhet i munnen, utslett, følelse av svakhet, ekstrem tretthet, vannansamling som fører til hevelse i hender, ankler eller føtter, feber, leddsmerter og seksualproblemer som nedsatt sexlyst hos menn og kvinner eller ereksjonsproblemer hos menn.
English: Development or exacerbation of diabetes occasionally associated with ketoacidosis or coma, including some fatal cases (see section 4.4)11
Norwegian Bokmål: Utvikling eller forverring av diabetes av og til assosiert med ketoacidose eller koma, inkludert enkelte fatale tilfeller (se pkt.
English: Respiratory, thoracic and mediastinal disorders Epistaxis9
Norwegian Bokmål: Sykdommer i respirasjonsorganer, thorax og mediastinum
English: Elevated cholesterol
Norwegian Bokmål: Vanlige: Forhøyede kolesterolnivåer
English: What you need to know before you take Olanzapine Teva 3.
Norwegian Bokmål: Hva du må vite før du bruker Olanzapine Teva Bruk ikke Olanzapine Teva:
English: Glutamyltransfera se10
Norwegian Bokmål: Høy gamma glutamyltransferase
English: Tablet coating: hypromellose, polydextrose, glycerol triacetate, macrogol 8000, titanium dioxide (E171).
Norwegian Bokmål: Tablettdrasjering: hypromellose, polydextrose, glyceroltriacetat, makrogol 8000, titandioksid (E171).
English: Each orodispersible tablet contains 142.5 mg lactose, 0.7875 mg sucrose and 6.75 mg aspartame (E951).
Norwegian Bokmål: Hver smeltetablett inneholder 142,5 mg laktose, 0,7875 mg sukrose og 6,75 mg aspartam (E951).
English: 3 Observed for fasting normal levels at baseline (<5.17 mmol/l) which increased to high (≥6.2 mmol/l).
Norwegian Bokmål: 3 Observert for fastende normalverdier ved baseline (<5,17 mmol/l) som økte til høye verdier (≥6,2 mmol/l).
English: Changes in total fasting cholesterol levels from borderline at baseline (≥4.39-<5.17 mmol/l) to high (≥5.17 mmol/l) were very common.
Norwegian Bokmål: Forandringer i fastende totalkolesterolverdier fra borderline ved baseline (≥4,39-<5,17 mmol/l) til høye verdier (≥5,17 mmol/l)var svært vanlig.
English: Patients gaining ≥7%, ≥15% and ≥25% of their baseline body weight with long-term exposure (at least 48 weeks) were very common (64.4%, 31.7% and 12.3% respectively).
Norwegian Bokmål: Ved langtidsbehandling (minst 48 uker) var vektøkning ≥7 %, ≥15 % og ≥25 % av baseline kroppsvekt svært vanlig (henholdsvis 64,4 %, 31,7 % og 12,3 %).
English: Olanzapine Teva belongs to a group of medicines called antipsychotics and is used to treat the following conditions: - Schizophrenia, a disease with symptoms such as hearing, seeing or sensing things which are not there, mistaken beliefs, unusual suspiciousness, and becoming withdrawn.
Norwegian Bokmål: • Schizofreni, en sykdom med symptomer som at man hører, ser eller føler ting som ikke eksisterer, vrangforestillinger, ualminnelig mistenksomhet og tilbaketrukkenhet.
English: High creatine phosphokinase11
Norwegian Bokmål: Høy kreatinkinase11
English: During treatment for schizophrenia, manic episode and recurrence prevention in bipolar disorder, daily dosage may subsequently be adjusted on the basis of individual clinical status within the range 5-20 mg/day.
Norwegian Bokmål: Basert på individuell klinisk respons kan den daglige doseringen deretter justeres innenfor området 5-20 mg/dag, ved behandling av schizofreni, manisk episode og forebygging av nye episoder av bipolalidelse.
English: 5HT2A/2C, 5HT3, 5HT6; dopamine D1, D2, D3, D4, D5; cholinergic muscarinic receptors M1 M5; α1 adrenergic; and histamine H1 receptors.
Norwegian Bokmål: I prekliniske studier viste olanzapin et spekter av reseptoraffinitet (Ki; < 100 nM) for serotonin 5HT2A/2C, 5HT3, 5HT6, dopamin D1, D2, D3, D4, D5, kolinerge muskarinerge reseptorer M1-M5, adrenerge reseptorer og histamin H1 reseptorer.
English: Changes in fasting glucose from borderline at baseline (≥5.56-<7 mmol/l) to high (≥7 mmol/l) were very common.
Norwegian Bokmål: Forandringer i fastende glukose fra borderline ved baseline (≥5,56-<7 mmol/l) til høye verdier (≥7 mmol/l) var svært vanlig.
English: In renally impaired patients (creatinine clearance <10 ml/min) versus healthy subjects, there was no significant difference in mean elimination half-life (37.7 versus 32.4 hr) or clearance (21.2 versus 25.0 l/hr).
Norwegian Bokmål: Det var ingen signifikant forskjell i gjennomsnittlig eliminasjonshalveringstid (37,7 versus 32,4 timer) eller clearance (21,2 versus 25,0 l/time) hos pasienter med nedsatt nyrefunksjon (kreatininclearance <10 ml/min) versus friske frivillige.
English: 13 Following short term treatment (median duration 22 days), weight gain ≥7% of baseline body weight (kg) was very common (40.6%), ≥15% of baseline body weight was common (7.1%) and ≥25% was common (2.5%).
Norwegian Bokmål: 13 Ved korttidsbehandling (median varighet 22 dager) var vektøkning ≥7 % fra baseline kroppsvekt (kg) var svært vanlig (40,6 %), ≥15 % fra baseline kroppsvekt var vanlig (7,1 %) og ≥25 % var vanlig (2,5 %).
English: Olanzapine Teva 15 mg film-coated tablets EU/1/07/427/016 - 28 tablets, per box
Norwegian Bokmål: Olanzapine Teva 15 mg filmdrasjerte tabletter EU/1/07/427/016/NO - 28 tabletter pr. boks
English: 3 Observed for fasting normal levels at baseline (<5.17 mmol/l) which increased to high
Norwegian Bokmål: 3 Observert for fastende normalverdier ved baseline (<5,17 mmol/l) som økte til høye verdier
English: Colour mixture blue (polydextrose, hypromellose, glycerol triacetate, macrogol 8000, titanium dioxide E171, indigo carmine E132)
Norwegian Bokmål: Blå fargeblanding (polydekstrose, hypromellose, glyseroltriacetat, makrogol 8000, titandioksid E171, indigokarmin E132)
English: How to take Olanzapine Teva
Norwegian Bokmål: Hvordan du bruker Olanzapine Teva
English: Excipient with known effect Each film-coated tablet contains 68.9 mg lactose.
Norwegian Bokmål: Hjelpestoff med kjent effekt Hver filmdrasjerte tablett inneholder 68,9 mg laktose.
English: - The active substance is olanzapine.
Norwegian Bokmål: - Virkestoff er olanzapin.
English: How to store Olanzapine Teva
Norwegian Bokmål: Hvordan du oppbevarer Olanzapine Teva
English: Tardive dyskinesia Amnesia9
Norwegian Bokmål: Dystoni (inkludert ufrivillige øyebevegelser) Tardiv dyskinesi11 Amnesi9
English: Excipient with known effect Each film-coated tablet contains 275.5 mg lactose.
Norwegian Bokmål: Hjelpestoff med kjent effekt Hver filmdrasjerte tablett inneholder 275,5 mg laktose.
English: Olanzapine Teva 5 mg, 10 mg and 15 mg orodispersible tablets are available in cartons containing 28, 30, 35, 50, 56, 70 or 98 tablets.
Norwegian Bokmål: Olanzapine Teva 5 mg, 10 mg og 15 mg smeltetabletter er tilgjengelige i pakninger med 28, 30, 35, 50, 56, 70 eller 98 tabletter.
English: Hepatobiliary disorders Transient, asymptomatic elevations of hepatic aminotransferases (ALT, AST), especially in early treatment (see section 4.4)
Norwegian Bokmål: Forbigående, asymptomatiske forhøyelser av leveraminotransfera ser (ALAT, ASAT), særlig tidlig i behandlingen (se pkt.
English: Each orodispersible tablet contains 47.5 mg lactose, 0.2625 mg sucrose and 2.25 mg aspartame (E951).
Norwegian Bokmål: Hver smeltetablett inneholder 47,5 mg laktose, 0,2625 mg sukrose og 2,25 mg aspartam (E951).
English: Olanzapine Teva 7.5 mg film-coated tablets
Norwegian Bokmål: Olanzapine Teva 7,5 mg tabletter, filmdrasjerte
English: Excipient with known effect Each film-coated tablet contains 137.8 mg lactose.
Norwegian Bokmål: Hjelpestoff med kjent effekt Hver filmdrasjerte tablett inneholder 137,8 mg laktose.
English: Excipient with known effect Each film-coated tablet contains 206.7 mg lactose.
Norwegian Bokmål: Hjelpestoff med kjent effekt Hver filmdrasjerte tablett inneholder 206,7 mg laktose.
English: Tell your doctor immediately if you have: - unusual movement (a common side effect that may affect up to 1 in 10 people) mainly of the face or tongue; - blood clots in the veins (an uncommon side effect that may affect up to 1 in 100 people) especially in the legs (symptoms include swelling, pain, and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing.
Norwegian Bokmål: • boldpropper i venene (en mindre vanlig bivirkning som kan ramme opptil 1 av 100 personer), spesielt i leggene (symptomer omfatter hevelse, smerte og rødhet i leggen), som kan passere gjennom blodårene til lungene og forårsake brystsmerter og pustevanskeligheter.
English: The most frequently (seen in ≥1% of patients ) reported adverse reactions associated with the use of olanzapine in clinical trials were somnolence, weight gain, eosinophilia, elevated prolactin, cholesterol, glucose and triglyceride levels (see section 4.4), glucosuria, increased appetite, dizziness, akathisia, parkinsonism, leukopenia, neutropenia (see section 4.4), dyskinesia, orthostatic hypotension, anticholinergic effects, transient asymptomatic elevations of hepatic aminotransferases (see section 4.4), rash, asthenia, fatigue, pyrexia, arthralgia, increased alkaline phosphatase, high gamma glutamyltransferase, high uric acid, high creatine phosphokinase and oedema.
Norwegian Bokmål: De hyppigst (sett i ≥1 % av pasientene) rapporterte bivirkninger assosiert med bruk av olanzapin i kliniske utprøvinger var somnolens, vektøkning, eosinofili, forhøyede prolaktin-, kolesterol-, glukoseog triglyseridnivåer (se pkt.
English: Colour mixture pink (polydextrose, hypromellose, glycerol triacetate, macrogol 8000, titanium dioxide E171, iron oxide red E172)
Norwegian Bokmål: Rosa fargeblanding (polydekstrose, hypromellose, glyseroltriacetat, makrogol 8000, titandioksid E171, rødt jernoksid E172)
English: Each orodispersible tablet contains 190.0 mg lactose, 1.05 mg sucrose and 9.0 mg aspartame (E951).
Norwegian Bokmål: Hver smeltetablett inneholder 190,0 mg laktose, 1,05 mg sukrose og 9,054 mg aspartam (E951).
English: Olanzapine Teva 2.5 mg film-coated tablets Olanzapine Teva 5 mg film-coated tablets Olanzapine Teva 7.5 mg film-coated tablets Olanzapine Teva 10 mg film-coated tablets Olanzapine Teva 15 mg film-coated tablets Olanzapine Teva 20 mg film-coated tablets
Norwegian Bokmål: Olanzapine Teva 2,5 mg tabletter, filmdrasjert Olanzapine Teva 5 mg tabletter, filmdrasjert Olanzapine Teva 7,5 mg tabletter, filmdrasjert Olanzapine Teva 10 mg tabletter, filmdrasjert Olanzapine Teva 15 mg tabletter, filmdrasjert Olanzapine Teva 20 mg tabletter, filmdrasjert olanzapin
English: Each orodispersible tablet contains 95.0 mg lactose, 0.525 mg sucrose and 4.5 mg aspartame (E951).
Norwegian Bokmål: Hver smeltetablett inneholder 95,0 mg laktose, 0,525 mg sukrose og 4,5 mg aspartam (E951).
English: If you stop taking Olanzapine Teva
Norwegian Bokmål: Dersom du har glemt å ta Olanzapine Teva
English: Olanzapine Teva 20 mg film-coated tablets Each film-coated tablet contains 20 mg olanzapine.
Norwegian Bokmål: Olanzapine Teva 20 mg tabletter, filmdrasjerte Hver filmdrasjerte tablett inneholder 20 mg olanzapin.
English: OPA-Al-PVC/Al blisters in cartons of 28, 30, 35, 50, 56, 70 or 98 orodispersible tablets per carton.
Norwegian Bokmål: OPA-Al-PVC/Al blistere i pakninger med 28, 30, 35, 56, 70 eller 98 smeltetabletter per eske.
English: Olanzapine Teva 7.5 mg film-coated tablets Each film-coated tablet contains 7.5 mg olanzapine.
Norwegian Bokmål: Olanzapine Teva 7,5 mg tabletter, filmdrasjerte Hver filmdrasjerte tablett inneholder 7,5 mg olanzapin.
English: Discontinuation symptoms7,12
Norwegian Bokmål: Seponeringssymptomer12
English: EU/1/07/427/052 - 70 tablets, per box EU/1/07/427/062 - 98 tablets, per box
Norwegian Bokmål: EU/1/07/427/030/NO - 56 tabletter pr. boks EU/1/07/427/055/NO - 70 tabletter pr. boks EU/1/07/427/065/NO - 98 tabletter pr. boks
English: Orodispersible tablet
Norwegian Bokmål: Tablettdrasjering
English: Olanzapine Teva 2.5 mg film-coated tablets Each film-coated tablet contains 2.5 mg olanzapine.
Norwegian Bokmål: Olanzapine Teva 2,5 mg tabletter, filmdrasjerte Hver filmdrasjerte tablett inneholder 2,5 mg olanzapin.
English: Nervous system disorders Somnolence
Norwegian Bokmål: Eosinofili Leukopeni Nøytropeni
English: Sucrose
Norwegian Bokmål: Glukosuri
English: Olanzapine Teva 20 mg orodispersible tablets are available in cartons containing 28, 30, 35, 56, 70 or 98 tablets.
Norwegian Bokmål: Olanzapine Teva 20 mg smeltetabletter er tilgjengelig i pakninger med 28, 30, 35, 56, 70 eller 98 tabletter.
English: Olanzapine Teva 20 mg film-coated tablets
Norwegian Bokmål: Olanzapine Teva 20 mg tabletter, filmdrasjerte
English: EU/1/07/427/011 EU/1/07/427/012 EU/1/07/427/013 EU/1/07/427/014 EU/1/07/427/015 EU/1/07/427/041 EU/1/07/427/051 EU/1/07/427/061 EU/1/07/427/069 EU/1/07/427/083 EU/1/07/427/084 EU/1/07/427/085 EU/1/07/427/086 EU/1/07/427/087 EU/1/07/427/088 EU/1/07/427/089 EU/1/07/427/090
Norwegian Bokmål: EU/1/07/427/011/NO EU/1/07/427/012/NO EU/1/07/427/013/NO EU/1/07/427/014/NO EU/1/07/427/015/NO EU/1/07/427/041/NO EU/1/07/427/051/NO EU/1/07/427/061/NO EU/1/07/427/069/NO EU/1/07/427/083/NO EU/1/07/427/084/NO EU/1/07/427/085/NO EU/1/07/427/086/NO EU/1/07/427/087/NO EU/1/07/427/088/NO EU/1/07/427/089/NO EU/1/07/427/090/NO
English: Each Olanzapine Teva 7.5 mg film-coated tablet contains 7.5 mg of the active substance.
Norwegian Bokmål: Hver Olanzapine Teva 7,5 mg filmdrasjert tablett inneholder 7,5 mg virkestoff.
English: EU/1/07/427/035 EU/1/07/427/036 EU/1/07/427/037 EU/1/07/427/047 EU/1/07/427/057 EU/1/07/427/067
Norwegian Bokmål: EU/1/07/427/035/NO EU/1/07/427/036/NO EU/1/07/427/037/NO EU/1/07/427/047/NO EU/1/07/427/057/NO EU/1/07/427/067/NO
English: Each Olanzapine Teva 2.5 mg film-coated tablet contains 2.5 mg of the active substance.
Norwegian Bokmål: Hver Olanzapine Teva 2,5 mg filmdrasjert tablett inneholder 2,5 mg virkestoff.
English: Vascular disorders Orthostatic hypotension10
Norwegian Bokmål: Ortostatisk hypotensjon10
English: Olanzapine Teva 20 mg orodispersible tablets
Norwegian Bokmål: Olanzapine Teva 20 mg smeltetabletter
English: Olanzapine Teva 15 mg film-coated tablets OPA/alu/PVC-alu blisters in cartons of 28, 30, 35, 50, 56, 70 or 98 film-coated tablets per carton.
Norwegian Bokmål: Olanzapine Teva 15 mg tabletter, filmdrasjerte OPA/Aluminium/PVC-Aluminium blistere i pakninger med 28, 30, 35, 50, 56, 70 eller 98 filmdrasjerte tabletter per eske.
English: EU/1/07/427/016 EU/1/07/427/017 EU/1/07/427/018 EU/1/07/427/019 EU/1/07/427/042 EU/1/07/427/052 EU/1/07/427/062
Norwegian Bokmål: EU/1/07/427/016/NO EU/1/07/427/017/NO EU/1/07/427/018/NO EU/1/07/427/019/NO EU/1/07/427/042/NO EU/1/07/427/052/NO EU/1/07/427/062/NO
English: EU/1/07/427/008 EU/1/07/427/009 EU/1/07/427/010 EU/1/07/427/040 EU/1/07/427/050 EU/1/07/427/060 EU/1/07/427/068 EU/1/07/427/077 EU/1/07/427/078 EU/1/07/427/079 EU/1/07/427/080 EU/1/07/427/081 EU/1/07/427/082
Norwegian Bokmål: EU/1/07/427/008/NO EU/1/07/427/009/NO EU/1/07/427/010/NO EU/1/07/427/040/NO EU/1/07/427/050/NO EU/1/07/427/060/NO EU/1/07/427/068/NO EU/1/07/427/077/NO EU/1/07/427/078/NO EU/1/07/427/079/NO EU/1/07/427/080/NO EU/1/07/427/081/NO EU/1/07/427/082/NO
English: Very rare side effects include serious allergic reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
Norwegian Bokmål: Legemiddelinduse rt utslett med eosinofili og systemiske symptomer (DRESS)
English: Olanzapine Teva 5 mg film-coated tablets Each film-coated tablet contains 5 mg olanzapine.
Norwegian Bokmål: Olanzapine Teva 5 mg tabletter, filmdrasjerte Hver filmdrasjerte tablett inneholder 5 mg olanzapin.
English: Olanzapine Teva 15 mg film-coated tablets Each film-coated tablet contains 15 mg olanzapine.
Norwegian Bokmål: Olanzapine Teva 15 mg tabletter, filmdrasjerte Hver filmdrasjerte tablett inneholder 15 mg olanzapin.
English: Olanzapine Teva 10 mg orodispersible tablets
Norwegian Bokmål: Olanzapine Teva 10 mg smeltetabletter
English: Excipient with known effect Each film-coated tablet contains 103.3 mg lactose.
Norwegian Bokmål: Hver filmdrasjerte tablett inneholder 103,3 mg laktose.
English: Olanzapine Teva 10 mg film-coated tablets Each film-coated tablet contains 10 mg olanzapine.
Norwegian Bokmål: Olanzapine Teva 10 mg tabletter, filmdrasjerte Hver filmdrasjerte tablett inneholder 10 mg olanzapin.
English: Each Olanzapine Teva 10 mg orodispersible tablet contains 10 mg of the active substance.
Norwegian Bokmål: Hver Olanzapine Teva 10 mg smeltetablett inneholder 10 mg virkestoff.
English: EU/1/07/427/027 EU/1/07/427/028 EU/1/07/427/029 EU/1/07/427/030 EU/1/07/427/045 EU/1/07/427/055 EU/1/07/427/065
Norwegian Bokmål: EU/1/07/427/027/NO EU/1/07/427/028/NO EU/1/07/427/029/NO EU/1/07/427/030/NO EU/1/07/427/045/NO EU/1/07/427/055/NO EU/1/07/427/065/NO
English: EU/1/07/427/004 EU/1/07/427/005 EU/1/07/427/006 EU/1/07/427/007 EU/1/07/427/039 EU/1/07/427/049 EU/1/07/427/059 EU/1/07/427/070 EU/1/07/427/071 EU/1/07/427/072 EU/1/07/427/073 EU/1/07/427/074 EU/1/07/427/075 EU/1/07/427/076
Norwegian Bokmål: EU/1/07/427/004/NO EU/1/07/427/005/NO EU/1/07/427/006/NO EU/1/07/427/007/NO EU/1/07/427/039/NO EU/1/07/427/049/NO EU/1/07/427/059/NO EU/1/07/427/070/NO EU/1/07/427/071/NO EU/1/07/427/072/NO EU/1/07/427/073/NO EU/1/07/427/074/NO EU/1/07/427/075/NO EU/1/07/427/076/NO
English: Olanzapine Teva 20 mg film-coated tablet is a pink, biconvex, oval film-coated tablet, debossed ”OL 20” on one side and plain on the other.
Norwegian Bokmål: Olanzapine Teva 20 mg tablett, filmdrasjert er en rosa, bikonveks, oval filmdrasjert tablett, preget med ”OL 20” på en side og glatt på den andre siden.
English: Olanzapine Teva 5 mg orodispersible tablets
Norwegian Bokmål: Olanzapine Teva 5 mg smeltetabletter
English: EU/1/07/427/001 EU/1/07/427/002 EU/1/07/427/003 EU/1/07/427/038 EU/1/07/427/048 EU/1/07/427/058
Norwegian Bokmål: EU/1/07/427/001/NO EU/1/07/427/002/NO EU/1/07/427/003/NO EU/1/07/427/038/NO EU/1/07/427/048/NO EU/1/07/427/058/NO
English: Olanzapine Teva 5 mg orodispersible tablets Olanzapine Teva 10 mg orodispersible tablets Olanzapine Teva 15 mg orodispersible tablets Olanzapine Teva 20 mg orodispersible tablets
Norwegian Bokmål: Olanzapine Teva 5 mg smeltetablett Olanzapine Teva 10 mg smeltetablett Olanzapine Teva 15 mg smeltetablett Olanzapine Teva 20 mg smeltetablett olanzapin
English: Olanzapine Teva 10 mg film-coated tablets
Norwegian Bokmål: Olanzapine Teva 10 mg tabletter, filmdrasjerte
English: Olanzapine Teva 15 mg film-coated tablets
Norwegian Bokmål: Olanzapine Teva 15 mg tabletter, filmdrasjerte
English: 7 film-coated tablets 7 x 1 film-coated tablets 28 film-coated tablets 28 x 1 film-coated tablets 30 film-coated tablets 30 x 1 film-coated tablets 35 film-coated tablets 35 x 1 film-coated tablets 50 film-coated tablets 50 x 1 film-coated tablets 56 film-coated tablets 56 x 1 film-coated tablets 60 film-coated tablets 70 film-coated tablets 70 x 1 film-coated tablets 98 film-coated tablets 98 x 1 film-coated tablets
Norwegian Bokmål: 7 tabletter, filmdrasjerte 7 x 1 tabletter, filmdrasjerte 28 tabletter, filmdrasjerte 28 x 1 tabletter, filmdrasjerte 30 tabletter, filmdrasjerte 30 x 1 tabletter, filmdrasjerte 35 tabletter, filmdrasjerte 35 x 1 tabletter, filmdrasjerte 50 tabletter, filmdrasjerte 50 x 1 tabletter, filmdrasjerte 56 tabletter, filmdrasjerte 56 x 1 tabletter, filmdrasjerte 60 tabletter, filmdrasjerte 70 tabletter, filmdrasjerte 70 x 1 tabletter, filmdrasjerte 98 tabletter, filmdrasjerte 98 x 1 tabletter, filmdrasjerte
English: Each Olanzapine Teva 20 mg film-coated tablet contains 20 mg of the active substance.
Norwegian Bokmål: Hver Olanzapine Teva 20 mg filmdrasjert tablett inneholder 20 mg virkestoff.
English: EU/1/07/427/031 EU/1/07/427/032 EU/1/07/427/033 EU/1/07/427/034 EU/1/07/427/046 EU/1/07/427/056 EU/1/07/427/066
Norwegian Bokmål: EU/1/07/427/031/NO EU/1/07/427/032/NO EU/1/07/427/033/NO EU/1/07/427/034/NO EU/1/07/427/046/NO EU/1/07/427/056/NO EU/1/07/427/066/NO
English: Olanzapine Teva 7.5 mg film-coated tablets White, biconvex, round film-coated tablets, debossed ”OL 7.5” on one side and plain on the other.
Norwegian Bokmål: Olanzapine Teva 7,5 mg tablett, filmdrasjert er en hvit, bikonveks, rund filmdrasjert tablett, preget med ”OL 7,5” på en side og glatt på den andre siden.
English: Olanzapine Teva 5 mg orodispersible tablet is a yellow, round, biconvex tablet, with 8 mm of diameter.
Norwegian Bokmål: Olanzapine Teva 5 mg smeltetablett er en gul, rund, bikonveks tablett, 8 mm i diameter.